Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test in overweight and inactive adults whether the new PAI eHealh APP leads to better adherence to a physical activity regimen than the wearable step counter App from the market leader FitBit, and to evaluate if improved adherence will be reflected in a better cardiovascular profile in this group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PAI APP | Experimental | personal activity index application |
|
| FitBit APP | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pai APP | Device | prescribed 100 PAI weekly |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| The proportion of the participants obtaining 80 % or more of the prescribed physical activity for one year | Prescribed 100 PAI weekly (PAI app group), or 10 000 steps daily (step counter app) | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Cardiorespiratory fitness | Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany | 1 year |
| Cardiorespiratory fitness | Peak oxygen uptake assessed by Jaeger oxycon pro; Erich Jaeger GmbH, Hoechberg, Germany |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ulrik Wisløff, prof | Norwegian University of Science and Technology | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institutt for sirkulasjon og bildediagnostikk | Trondheim | Norway |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D009765 | Obesity |
| D010349 | Patient Compliance |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| FitBit APP | Device | prescribed 10000 steps daily |
|
|
| 16 weeks |
| Resting blood pressure | Left upper arm, right upper arm, orthostatic hypotension | 16 weeks |
| Resting blood pressure | Left upper arm, right upper arm, orthostatic hypotension | 1 year |
| Resting heart rate | 16 weeks |
| Resting heart rate | 1 year |
| Body mass index | Height, weight | 16 weeks |
| Body mass index | Height, weight | 1 year |
| Waist line | in centimeters | 16 weeks |
| Waist line | in centimeters | 1 year |
| Body composition | body composition measured by bioelectrical impedance (InBody 720, BIOSPACE, Seoul, Korea) | 16 weeks |
| Body composition | body composition measured by bioelectrical impedance (InBody 720, BIOSPACE, Seoul, Korea) | 1 year |
| Activity questionnaire | HUNT-1 questionnaire 2 "exercise" | 16 weeks |
| Activity questionnaire | HUNT-1 questionnaire 2 "exercise" | 1 year |
| glucose concentration in blood | 16 weeks |
| glucose concentration in blood | 1 year |
| glycosylated haemoglobin (HbA1c) concentration in blood | 16 weeks |
| glycosylated haemoglobin (HbA1c) concentration in blood | 1 year |
| c-peptide concentration in blood | 16 weeks |
| c-peptide concentration in blood | 1 year |
| concentration of triglycerides in blood serum | 16 weeks |
| concentration of triglycerides in blood serum | 1 year |
| concentration of total cholesterol in blood | 16 weeks |
| concentration of total cholesterol in blood | 1 year |
| concentration of low density lipid (LDL) cholesterol in blood | 16 weeks |
| concentration of low density lipid (LDL) cholesterol in blood | 1 year |
| concentration of high density lipid (HDL) cholesterol in blood | 16 weeks |
| concentration of high density lipid (HDL) cholesterol in blood | 1 year |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |